BusinessBioLargo Completes Study of Breakthrough Water Treatment Technology for Poultry Process Water and Municipal Wastewater TreatmentBy Nasdaq OMXFeb 6, 2018, 1:32 PM UTC
BusinessBioLargo, Inc. to Present at 10th Annual LD Micro Investor Conference on its Disruptive Clean Water, Clean Air, and Advanced Wound Care TechnologiesBy Nasdaq OMXDec 4, 2017, 3:46 PM UTC
BusinessBioLargo Sets New Sales Records and Continues to Break Through Commercial BarriersBy Nasdaq OMXNov 14, 2017, 2:30 PM UTC
BusinessBioLargo's Medical Subsidiary Files 510(k) with FDA for its Novel Wound Care TechnologyBy Nasdaq OMXSep 28, 2017, 1:12 PM UTC
BusinessBioLargo Acquires World-Class Engineering Team to Form a New Engineering Services Subsidiary and Enters into Common Stock Purchase Agreement for Up to $10 Million with Lincoln Park CapitalBy Nasdaq OMXSep 11, 2017, 1:30 PM UTC
BusinessBioLargo’s 3rd Annual Technical Symposium Showcases its Advanced Oxidation System (AOS) and First Commercial Validation Trials Performance ResultsBy Nasdaq OMXAug 22, 2017, 12:00 PM UTC
